Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.
Limits on travel and visa appointments have delayed or prevented foreign doctors from entering the country for jobs set to begin in weeks.
Researchers found children with highly addictive use of phones, video games or social media were two to three times as likely to have thoughts of suicide or to harm themselves.
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
Dr. Fiona Havers is influential among researchers who study immunizations. The wholesale dismissal of the agency’s scientific advisers crossed the line, she said.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.
Once nearly eradicated, the “old man’s disease” is back and suffocating younger miners. Federal cuts risk putting a solution further out of reach.
The judge accused the Trump administration of discriminating against racial minorities and L.G.B.T.Q. people and ordered the government to restore much of the funding.
The question for the justices is whether the centers may pursue a First Amendment challenge to a state subpoena seeking donor information in federal court.
Hundreds of graduate students are writing to their hometown newspapers to defend their research, as the Trump administration drastically reduces science funding.
The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.
Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have filed statements in court flagging concerns about vaccines.
